SELECT Trial and Implications for Population Health
Vložit
- čas přidán 10. 11. 2023
- Chiadi Ndumele MD, MHS, Phd and Tiffany Powell-Wiley, MD, MPH discuss the results of the SELECT trial and the potential impact of the semaglutide as a treatment for obesity.
Follow us at @AHAScience and see full coverage of #AHA23 at professional.heart.org/en/mee... - Věda a technologie
HFpEF is probably most common in elderly women living on very modest means. Semaglutide costs more than many persons entire Social Security income.